A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma

ObjectiveWe sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on random survival forests (RSF).MethodsWe retrospectively analyzed...

Full description

Bibliographic Details
Main Authors: Huapeng Lin, Lingfeng Zeng, Jing Yang, Wei Hu, Ying Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.608260/full
id doaj-4dddd93f2d8b406a93e6ec1b38923246
record_format Article
spelling doaj-4dddd93f2d8b406a93e6ec1b389232462021-03-02T15:06:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.608260608260A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular CarcinomaHuapeng Lin0Huapeng Lin1Lingfeng Zeng2Jing Yang3Wei Hu4Ying Zhu5Department of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaObjectiveWe sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on random survival forests (RSF).MethodsWe retrospectively analyzed overall survival rates of patients with BCLC stage B HCC using a training (n = 602), internal validation (n = 301), and external validation (n = 343) groups. We extracted twenty-one clinical and biochemical parameters with established strategies for preprocessing, then adopted the RSF classifier for variable selection and model development. We evaluated model performance using the concordance index (c-index) and area under the receiver operator characteristic curves (AUROC).ResultsRSF revealed that five parameters, namely size of the tumor, BCLC-B sub-classification, AFP level, ALB level, and number of lesions, were strong predictors of survival. These were thereafter used for model development. The established model had a c-index of 0.69, whereas AUROC for predicting survival outcomes of the first three years reached 0.72, 0.71, and 0.73, respectively. Additionally, the model had better performance relative to other eight Cox proportional-hazards models, and excellent performance in the subgroup of BCLC-B sub-classification B I and B II stages.ConclusionThe RSF-based model, established herein, can effectively predict survival of patients with BCLC stage B HCC, with better performance than previous Cox proportional hazards models.https://www.frontiersin.org/articles/10.3389/fonc.2021.608260/fullhepatocellular carcinomaBCLC Stage Bmachine learningrandom survival forestprognosis
collection DOAJ
language English
format Article
sources DOAJ
author Huapeng Lin
Huapeng Lin
Lingfeng Zeng
Jing Yang
Wei Hu
Ying Zhu
spellingShingle Huapeng Lin
Huapeng Lin
Lingfeng Zeng
Jing Yang
Wei Hu
Ying Zhu
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
Frontiers in Oncology
hepatocellular carcinoma
BCLC Stage B
machine learning
random survival forest
prognosis
author_facet Huapeng Lin
Huapeng Lin
Lingfeng Zeng
Jing Yang
Wei Hu
Ying Zhu
author_sort Huapeng Lin
title A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
title_short A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
title_full A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
title_fullStr A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
title_full_unstemmed A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
title_sort machine learning-based model to predict survival after transarterial chemoembolization for bclc stage b hepatocellular carcinoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-03-01
description ObjectiveWe sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on random survival forests (RSF).MethodsWe retrospectively analyzed overall survival rates of patients with BCLC stage B HCC using a training (n = 602), internal validation (n = 301), and external validation (n = 343) groups. We extracted twenty-one clinical and biochemical parameters with established strategies for preprocessing, then adopted the RSF classifier for variable selection and model development. We evaluated model performance using the concordance index (c-index) and area under the receiver operator characteristic curves (AUROC).ResultsRSF revealed that five parameters, namely size of the tumor, BCLC-B sub-classification, AFP level, ALB level, and number of lesions, were strong predictors of survival. These were thereafter used for model development. The established model had a c-index of 0.69, whereas AUROC for predicting survival outcomes of the first three years reached 0.72, 0.71, and 0.73, respectively. Additionally, the model had better performance relative to other eight Cox proportional-hazards models, and excellent performance in the subgroup of BCLC-B sub-classification B I and B II stages.ConclusionThe RSF-based model, established herein, can effectively predict survival of patients with BCLC stage B HCC, with better performance than previous Cox proportional hazards models.
topic hepatocellular carcinoma
BCLC Stage B
machine learning
random survival forest
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.608260/full
work_keys_str_mv AT huapenglin amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT huapenglin amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT lingfengzeng amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT jingyang amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT weihu amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT yingzhu amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT huapenglin machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT huapenglin machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT lingfengzeng machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT jingyang machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT weihu machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
AT yingzhu machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma
_version_ 1724234743755571200